Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national blog main
national top stories
new york blog main
new york top stories
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
4
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
agios pharmaceuticals
biotech
fda
life sciences
abeona therapeutics
affordable care act
alirocuma
alzheimer's
ameet nathwani
arches
bristol-myers squibb
cancer
clinical trials
david schenkein
What
american
4
×
roundup
u.s
annual
based
best
bio
continue
crash
debate
healthcare
industry
kind
nash
people
pharmaceutical
policy
politicians
pressure
scalps
society
trump’s
ahead
ambien
asco
ash
attendees
attention
biotech
blood
borne
camp’s
cancer
cancers
cash
chicago
city
clinical
combinations
community’s
Language
Current search:
sanofi
×
american
×
" new york top stories "
×
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More